Wick Capital Partners LLC Invests $761,000 in Danaher Corporation $DHR

Wick Capital Partners LLC purchased a new stake in Danaher Corporation (NYSE:DHR) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 3,324 shares of the conglomerate’s stock, valued at approximately $761,000.

A number of other large investors have also made changes to their positions in the company. Compound Planning Inc. increased its holdings in shares of Danaher by 47.1% in the fourth quarter. Compound Planning Inc. now owns 9,554 shares of the conglomerate’s stock worth $2,187,000 after acquiring an additional 3,060 shares in the last quarter. Invesco Ltd. lifted its holdings in shares of Danaher by 8.1% during the 4th quarter. Invesco Ltd. now owns 4,120,223 shares of the conglomerate’s stock valued at $943,201,000 after purchasing an additional 307,095 shares in the last quarter. Evansbrook LLC acquired a new position in shares of Danaher in the 4th quarter valued at approximately $282,000. Birchwood Financial Partners Inc. acquired a new position in shares of Danaher in the 4th quarter valued at approximately $41,000. Finally, Corient Private Wealth LLC increased its stake in Danaher by 2.0% during the 4th quarter. Corient Private Wealth LLC now owns 1,025,570 shares of the conglomerate’s stock worth $228,812,000 after purchasing an additional 19,852 shares in the last quarter. Institutional investors own 79.05% of the company’s stock.

Danaher Trading Down 0.0%

NYSE:DHR opened at $177.74 on Friday. Danaher Corporation has a twelve month low of $160.93 and a twelve month high of $242.80. The company has a quick ratio of 1.52, a current ratio of 1.87 and a debt-to-equity ratio of 0.33. The business has a 50 day moving average price of $179.99 and a two-hundred day moving average price of $203.25. The company has a market cap of $125.80 billion, a P/E ratio of 34.38, a price-to-earnings-growth ratio of 2.27 and a beta of 0.81.

Danaher (NYSE:DHR) last issued its quarterly earnings results on Monday, April 20th. The conglomerate reported $2.06 earnings per share for the quarter, topping the consensus estimate of $1.94 by $0.12. The company had revenue of $5.95 billion during the quarter, compared to analysts’ expectations of $6 billion. Danaher had a net margin of 14.89% and a return on equity of 10.91%. The business’s quarterly revenue was up 3.7% on a year-over-year basis. During the same period last year, the business earned $1.88 EPS. As a group, analysts expect that Danaher Corporation will post 8.45 EPS for the current fiscal year.

Danaher Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Friday, June 26th will be given a $0.40 dividend. The ex-dividend date of this dividend is Friday, June 26th. This represents a $1.60 dividend on an annualized basis and a yield of 0.9%. Danaher’s dividend payout ratio (DPR) is 30.95%.

Analysts Set New Price Targets

Several analysts have commented on DHR shares. DZ Bank initiated coverage on shares of Danaher in a report on Wednesday, June 3rd. They set a “buy” rating and a $210.00 target price on the stock. The Goldman Sachs Group lowered their price objective on shares of Danaher from $265.00 to $230.00 and set a “buy” rating for the company in a research report on Monday, April 13th. Rothschild & Co Redburn set a $205.00 price objective on shares of Danaher in a report on Friday, April 17th. Wolfe Research cut shares of Danaher from an “outperform” rating to a “peer perform” rating in a research report on Monday, June 1st. Finally, Robert W. Baird cut their price objective on shares of Danaher from $251.00 to $249.00 and set an “outperform” rating on the stock in a research report on Friday, April 17th. One investment analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and five have given a Hold rating to the company’s stock. According to MarketBeat.com, Danaher currently has a consensus rating of “Moderate Buy” and an average price target of $233.61.

Danaher Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.